Trademark: 79299661
Word
PSARLINK
Status
Registered
Status Code
700
Status Date
Tuesday, October 26, 2021
Serial Number
79299661
Registration Number
6532857
Registration Date
Tuesday, October 26, 2021
Mark Type
4
Filing Date
Wednesday, July 15, 2020
Published for Opposition
Tuesday, August 10, 2021

Trademark Owner History
MABLINK BIOSCIENCE - Original Registrant

Classifications
5 Pharmaceutical preparations for the treatment of cancer ; pharmaceutical products for the prevention or treatment of human diseases, namely, the treatment of cancer; chemical, biological and biochemical products for medical and pharmaceutical use, namely, antibody-drug conjugates and any protein combined with a drug, a polynucleotide, another protein, a chemical entity, or another functional entity, and used as medical binders or fillers; pharmaceutical preparations, namely bioconjugates, intended for the diagnosis and treatment of diseases, namely, cancer ; antibody products, namely, antibody or protein bioconjugates for the medical diagnosis and treatment of cancer, namely, antibody/protein drug conjugates, antibody/protein labeled conjugates and antibody/protein imaging agent conjugates; delivery devices for antibodies, namely, drugs delivery agent in the form of antibodies drug conjugates that facilitate the delivery and action of medical preparations ; molecules and biomolecules, namely, reagents, antibody fragments, antibodies, all intended for medical diagnosis and disease treatment; pharmaceutical products, preparations and medical articles, namely, antibodies, antibody conjugates and active principles and antibody conjugates for medical purposes; chemical reagents for medical use, namely, chemical reagents to bind molecules for medical use; chemical reagents for the functionalization of biomolecules for medical use
1 Chemical, biochemical, biological and biotechnological preparations for use in industry and science ; chemical substances for the manufacture of pharmaceutical products for non-medical purposes, namely, for use in manufacturing of antibody conjugates ; chemical substances for tethering molecules, in particular chemical substances for tethering molecules for cancer therapy, for research in active substances and medicines other than for medical or veterinary purposes; chemical substances for the formation of antibody conjugates for use in laboratories, other than for medical or veterinary purposes ; chemical reagents for scientific purposes other than for medical or veterinary purposes; reagents for scientific or medical research; chemical, biochemical and biological reagents for scientific or medical research use; chemicals for bioconjugation, reversible cysteine protection, surface modification, and the production of prodrugs for use in laboratories, other than for medical or veterinary purposes; antibodies and antibody conjugates for scientific purposes, other than for medical or veterinary purposes; antibodies for scientific or medical research; molecules and biomolecules, namely, reagents, antibody fragments, antibodies, all intended for fundamental research and development, medical research and scientific diagnosis; Diagnostic products for scientific or research use related to conjugated antibodies, namely, diagnostic preparations for scientific use

Trademark Events
Dec 10, 2020
Sn Assigned For Sect 66a Appl From Ib
Jan 24, 2021
Refusal Processed By Ib
Dec 14, 2020
New Application Office Supplied Data Entered
Dec 14, 2020
Assigned To Examiner
Dec 18, 2020
Application Filing Receipt Mailed
Dec 18, 2020
Non-Final Action Written
Dec 19, 2020
Non-Final Action (Ib Refusal) Prepared For Review
Jan 5, 2021
Refusal Processed By Mpu
Jan 5, 2021
Non-Final Action Mailed - Refusal Sent To Ib
Jun 24, 2021
Teas Response To Office Action Received
Jun 24, 2021
Correspondence Received In Law Office
Jun 24, 2021
Teas/Email Correspondence Entered
Jul 5, 2021
Approved For Pub - Principal Register
Aug 10, 2021
Official Gazette Publication Confirmation E-Mailed
Jul 21, 2021
Notification Of Notice Of Publication E-Mailed
Jul 28, 2021
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Jul 28, 2021
Notification Of Possible Opposition Sent To Ib
Aug 10, 2021
Published For Opposition
Aug 15, 2021
Notification Processed By Ib
Oct 26, 2021
Registered-Principal Register
Jan 26, 2022
Final Disposition Notice Created, To Be Sent To Ib
Mar 14, 2024
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Mar 14, 2024
Teas Change Of Correspondence Received
Apr 18, 2022
Final Disposition Processed
Apr 18, 2022
Final Disposition Notice Sent To Ib
May 9, 2022
Final Decision Transaction Processed By Ib
Mar 14, 2024
Teas Change Of Owner Address Received
Mar 14, 2024
Attorney/Dom.Rep.Revoked And/Or Appointed
Mar 14, 2024
Applicant/Correspondence Changes (Non-Responsive) Entered
Apr 28, 2024
New Representative At Ib Received

Trademark Alertz updated from USPTO on 2030-01-24